維他奶(00345.HK)中期純利升332.3%至1.42億港元 中期息1.3港仙
格隆匯11月18日丨維他奶(00345.HK)公佈截至2022年9月30日止6個月的中期業績,期內集團實現收入36.42億港元,同比增長1.0%;毛利17.38億港元,同比增長0.6%,毛利率維持在48%;經營溢利2.12億港元,同比增長398.8%;公司股權持有人應占溢利1.42億港元,同比增長332.3%;每股基本盈利13.3港仙,宣派中期股息每股1.3港仙。
公吿稱,由於公司的團隊專注本業以確保可持續及盈利的收入增長,令盈利能力亦有所提升。經營溢利增加近400%,主要是由於中國內地的表現強勁、重新調整廣吿和推廣的推出時間以及支出、加上香港特區的政府補貼、以及經營費用減少所致。而溢利升幅卻抵銷部份因通脹壓力和不同地區經濟復甦緩慢等而減少的毛利。撇除2019冠狀病毒病疫情相關的政府補貼,經營溢利應可錄得近300%的改善。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.